Telehealth Goes Mainstream: The Doctor Will Virtually See You Now
COVID-19 ushered in a fundamental change in how medicine is being delivered.
Tag Archives: Medicare
Population Health Solutions Can Improve Value-Based Quality Measures and Reporting During a Pandemic
To achieve success in this market, device manufacturers should consider working with providers to help contain costs and enhance outcomes.
The Future of MedTech and Healthcare: No Boundary on Uniting Forces
All industries under the healthcare umbrella should embrace each other’s capabilities because no single category of player can master it and bring to consumers all that we need and demand, says Stephen Bernstein of McDermott Will & Emery.
How COVID-19 May Be the Catalyst in Ensuring a Healthy Future for Telemedicine
With everything to gain, telehealth may lead to a new standard in health/wellness treatment while at the same time unifying the entire healthcare ecosystem.
In Design of Virtual Care Tech, ‘User Experience Can’t Be an Afterthought’
In a Q&A with Zipnosis, Catherine Murphy explains the uptick in telehealth visits and how it is changing the continuum of care.
Be Prepared for Accelerated Adoption of AI in Wearables
Personalized medicine is the future of healthcare, and artificial intelligence will play a big role.
Innovative Technologies Help Battle Nation’s Chronic Liver Disease Epidemic
The adoption of accurate non-invasive measures of liver health at the point of care is critical.
Six Concepts to Navigate Manufacturer-Sponsored Clinical Trials
What you need to learn before thinking about seeking Medicare reimbursement for a clinical trial.
What you need to learn before thinking about seeking Medicare reimbursement for a clinical trial.
The OIG Work plan: Potential Implications for Medical Device Manufacturers and Suppliers
This year’s work plan includes several items that will impact medical device manufacturer and suppliers.
Seeking Reimbursement During IDE Clinical Trials
Billing in clinical trials has changed recently, so here is a summary of where it has been and where it is heading.
Billing in clinical trials has changed recently, so here is a summary of where it has been and where it is heading.
